US 10112956
Heterocyclic compounds having cholesterol 24-hydroxylase activity
granted A61KA61K9/2018A61K9/4858
Quick answer
US patent 10112956 (Heterocyclic compounds having cholesterol 24-hydroxylase activity) held by Takeda Pharmaceutical Company Limited expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K9/2018, A61K9/4858, A61P, A61P25/00